Hemodynamic forces as a stimulus for arteriogenesis

Nitzan Resnick1, Shmeul Einav, Limor Chen-Konak

  • 1Department of Anatomy and Cell Biology, The Rappaport Family Institute for Research in the Medical Sciences and the Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. nitzanr@tx.technion.ac.il

Insights

Understanding how collateral vessels form in ischemic heart disease is key to new treatments. This study explores the role of biomechanical forces and molecular mechanisms in promoting collateral vessel development for better heart function.

Area of Science:

  • Cardiovascular Biology
  • Biomedical Engineering
  • Molecular Medicine

Background:

  • Ischemic heart diseases represent a significant economic and health burden in Western societies.
  • Patient symptoms and heart damage do not always correlate with arterial occlusion severity.
  • Well-developed collateral vessels can compensate for reduced blood supply in some patients.

Purpose of the Study:

  • To summarize recent advances in understanding collateral vessel development.
  • To highlight the authors' perspective on the role of biomechanical forces.
  • To explore the underlying molecular mechanisms of collateral formation.

Main Methods:

  • Review of current literature on collateral vessel development.
  • Analysis of biomechanical forces influencing angiogenesis.
  • Investigation of molecular pathways involved in collateral formation.

Main Results:

  • Collateral vessel development is a complex process influenced by multiple factors.
  • Biomechanical forces play a central role in promoting collateral formation.
  • Specific molecular mechanisms are being identified that regulate this process.

Conclusions:

  • Understanding collateral vessel development offers a novel therapeutic strategy for ischemic heart disease.
  • Targeting biomechanical forces and molecular pathways could promote collateral formation.
  • This approach may lead to improved treatment outcomes for patients with reduced heart function.

Related Concept Videos

Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Blood Flow01:29

Blood Flow

Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Arteries and Arterioles01:16

Arteries and Arterioles

Arteries, the vasculature responsible for transporting blood from the heart, possess robust walls capable of enduring the elevated pressures exerted by the heartbeat. Arteries near the heart are especially thick-walled and enriched with elastic fibers across their three tunics, classifying them as elastic or conducting arteries. These arteries, usually with a diameter exceeding 10 mm, are characterized by their ability to dilate in response to the blood pumped from the heart's ventricles and...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...